Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Top.GainersTop.Gainers highlighting the top gainers of the day, providing timely updates and insights on the market's highest achievers.
22 Apr 2025Oblong ($OBLG), soaring nearly 64% after the company authorized a stock buyback program. With only 10K in average daily volume historically, the surge to nearly 20 million shares traded underscores the sheer scale of speculative interest this announcement unleashed. Buybacks tend to send a strong signal to the market, suggesting management believes the stock is undervalued — and traders clearly bought into the narrative.
One of the most talked-about moves came from NovaGold ($NG), which spiked nearly 40% following news that it’s acquiring Barrick Gold’s 50% stake in the Donlin Gold project — a massive Alaskan mining development — for up to $1.1 billion. The deal, backed by billionaire John Paulson, drastically changes NovaGold’s strategic positioning and long-term value proposition. Investors are betting this high-stakes acquisition could supercharge NG’s growth prospects if Donlin proves fruitful.
Also seeing solid upside was 908 Devices ($MASS), climbing nearly 18% after it received a $2 million order from the Texas Department of Public Safety. While the order itself isn’t groundbreaking in size, the deal serves as a confidence boost in the company’s value to government clients, especially as MASS looks to grow its footprint in the forensic and law enforcement sectors.
Bicycle Therapeutics ($BCYC) gained over 16%, as investor sentiment appeared to shift in favor of the biotech name, despite the lack of fresh catalysts. Some analysts suggest that BCYC’s previous selloff may have been overdone, and today’s bounce could mark a revaluation in progress. Bargain-hunting and short-covering may both be at play here.
Another name that drew headlines was Equifax ($EFX), which jumped nearly 14% after delivering a trifecta of good news: an earnings beat, a $3 billion share repurchase authorization, and a 28% dividend hike. The financials beat expectations across the board, and while management did caution about macro uncertainty, traders zeroed in on the shareholder-friendly moves as a bullish signal for the stock’s near-term trajectory.
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
